company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4519000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4519000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-127000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4615000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4615000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q3,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4613000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5718000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5718000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,93000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,585000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5027000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5027000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,22732000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22746000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22746000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2013.0,Q4,2012-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,17719000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5790000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5790000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,287000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-124000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5616000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5616000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,52976000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52978000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52978000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:23:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47359000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6192000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6192000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,335000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,573000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5273000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5273000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-907000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-116000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1023000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1023000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6298000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9468000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9468000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,691000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1278000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7486000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7486000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-78000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-78000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-78000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1128000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,96292000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,95164000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,95164000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,87600000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12361000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12361000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1326000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3782000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7237000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7237000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,83000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,128000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,211000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,211000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-250000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-249000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-249000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7275000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16871000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16871000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1773000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,470000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14606000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14606000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-110000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-110000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-110000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-35000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,147000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,112000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,112000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:18:55+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14604000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25027000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25027000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6185000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,367000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18443000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18443000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-71000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-71000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-423000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,130009000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,129586000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,129586000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,111072000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24035000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24035000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4407000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,84000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19515000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19515000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,21000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-90000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,227000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,137000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,137000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19357000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28562000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28562000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4086000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7689000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16755000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16755000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,160000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,198000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,358000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,358000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-36000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,67000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16366000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30543000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30543000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3714000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-647000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27435000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27435000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-341000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-341000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-341000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-599000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,141302000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,140703000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,140703000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 19:01:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,112927000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34747000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34747000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,75000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4196000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3792000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26671000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26671000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-494000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-82997000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-525000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-84016000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-84016000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110677000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37796000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37796000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,74000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4354000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2489000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30796000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30796000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-66000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35653000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7999000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27720000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27720000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,189591000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,189591000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,131075000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55901000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55901000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,82000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-373000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11512000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18568000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26112000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26112000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-520000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-140443000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22500000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,525000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-117938000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-117938000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1198000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1876000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,678000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-143372000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56778000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56778000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,130000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,33000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6208000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4803000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-55210000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-55210000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-245000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18908000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50753000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31600000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31600000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,553000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,553000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,553000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 07:17:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23057000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-70201000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-70201000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,130000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-38000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9350000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1859000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-58900000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-58900000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15014000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59683000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,44593000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,44593000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2758000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2758000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2758000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11549000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-73719000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-73719000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,136000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,62000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9780000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17269000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-46472000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-46472000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-235000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59894000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104000000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,43871000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,43871000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3687000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3687000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3687000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1086000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-69422000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-69422000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,135000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,236000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10301000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3105000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-55645000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-55645000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-804000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-150587000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46789000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-104602000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-104602000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,335178000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,335178000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,334820000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,174573000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74598000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74598000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,247000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1348000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15821000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7989000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-65171000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65171000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-652000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-394109000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81960000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-312801000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-312801000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,644486000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,904000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,645390000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,643112000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 07:16:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,265140000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16978000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16978000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,246000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2806000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29099000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,29932000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,45105000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,45105000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-402000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-419228000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,181500000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-238130000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-238130000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6540000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-186485000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-122918000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-122918000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,287000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2747000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25568000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5837000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-100153000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-100153000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-998000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-459622000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,460672000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,52000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,52000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8078000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8078000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8078000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-92023000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-158388000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-158388000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,363000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2991000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31690000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,34030000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-89314000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-89314000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-808000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-211399000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,250625000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,38418000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,38418000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1628000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1628000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1628000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49268000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-163406000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-163406000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,415000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2322000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,44855000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31458000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-147272000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-147272000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1257000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-580916000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,307263000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-274910000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-274910000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,577028000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,692000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,577720000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,576196000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:21:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,154014000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-168221000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-168221000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,505000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2651000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,35915000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,24747000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-104403000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-104403000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2181000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-337317000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,281389000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58109000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58109000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15343000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-147169000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-179958000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-179958000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,698000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1456000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,38010000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9427000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-130367000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-130367000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1940000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-159469000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,369188000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,207779000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,207779000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13919000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,91331000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-168653000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-168653000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,665000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,537000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,38125000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12922000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-116404000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-116404000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-373000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-230973000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,213430000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17916000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17916000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2166000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2166000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2166000.0
SAGE Therapeutics Inc,SAGE,5493000JX4BJS9W6CN35,0001597553,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-132154000.0
